메뉴 건너뛰기




Volumn 30, Issue 4, 2013, Pages

Clinical significance of serum soluble interleukin-2 receptor-α in extranodal natural killer/T-cell lymphoma (ENKTL): A predictive biomarker for treatment efficacy and valuable prognostic factor

Author keywords

CD25; Extranodal natural killer T cell lymphoma; Prognosis; Soluble interleukin 2 receptor; Targeted therapy

Indexed keywords

ASPARAGINASE; BIOCHEMICAL MARKER; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; OXALIPLATIN; PREDNISONE; SOLUBLE INTERLEUKIN 2 RECEPTOR; SOLUBLE INTERLEUKIN 2 RECEPTOR ALPHA; UNCLASSIFIED DRUG; VINCRISTINE;

EID: 84883704858     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0723-4     Document Type: Article
Times cited : (18)

References (38)
  • 1
    • 65349135347 scopus 로고    scopus 로고
    • Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma
    • 19318493 10.1158/1078-0432.CCR-08-2914
    • Li YX, Liu QF, Fang H, et al. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma. Clin Cancer Res. 2009;15:2905-12.
    • (2009) Clin Cancer Res , vol.15 , pp. 2905-2912
    • Li, Y.X.1    Liu, Q.F.2    Fang, H.3
  • 2
    • 51649091675 scopus 로고    scopus 로고
    • International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
    • 18626005 10.1200/JCO.2008.16.4558
    • Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124-30.
    • (2008) J Clin Oncol , vol.26 , pp. 4124-4130
    • Vose, J.1    Armitage, J.2    Weisenburger, D.3
  • 3
    • 53549130011 scopus 로고    scopus 로고
    • Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type
    • 18756548 10.1002/ajh.21256
    • Wang B, Li XQ, Ma X, et al. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type. Am J Hematol. 2008;83:795-9.
    • (2008) Am J Hematol , vol.83 , pp. 795-799
    • Wang, B.1    Li, X.Q.2    Ma, X.3
  • 4
    • 81755172136 scopus 로고    scopus 로고
    • Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: The NK-Cell tumor study group study
    • 21990393 10.1200/JCO.2011.35.6287 1:CAS:528:DC%2BC38Xns1Sgsw%3D%3D
    • Yamaguchi M, Kwong YL, Kim WS, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell tumor study group study. J Clin Oncol. 2011;29(33):4410-6.
    • (2011) J Clin Oncol , vol.29 , Issue.33 , pp. 4410-4416
    • Yamaguchi, M.1    Kwong, Y.L.2    Kim, W.S.3
  • 5
    • 79951483189 scopus 로고    scopus 로고
    • Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
    • 21123825 10.1182/blood-2010-09-307454 1:CAS:528:DC%2BC3MXisFKqs7s%3D
    • Jaccard A, Gachard N, Marin B, et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood. 2011;117(6):1834-9.
    • (2011) Blood , vol.117 , Issue.6 , pp. 1834-1839
    • Jaccard, A.1    Gachard, N.2    Marin, B.3
  • 6
    • 84872087371 scopus 로고    scopus 로고
    • First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma
    • 22811078 10.1002/cncr.27752 1:CAS:528:DC%2BC3sXjs1yqtg%3D%3D
    • Wang L, Wang ZH, Chen XQ, et al. First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma. Cancer. 2013;119:348-55.
    • (2013) Cancer , vol.119 , pp. 348-355
    • Wang, L.1    Wang, Z.H.2    Chen, X.Q.3
  • 9
    • 84872183512 scopus 로고    scopus 로고
    • Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients
    • 22983648 10.1007/s12185-012-1174-y 1:CAS:528:DC%2BC38XhslClu73K
    • Wang L, Xia ZJ, Huang HQ, et al. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients. Int J Hematol. 2012;96:617-23.
    • (2012) Int J Hematol , vol.96 , pp. 617-623
    • Wang, L.1    Xia, Z.J.2    Huang, H.Q.3
  • 10
    • 84867810745 scopus 로고    scopus 로고
    • SMILE for natural killer/T-cell lymphoma: Analysis of safety and efficacy from the Asia lymphoma study group
    • 22919026 10.1182/blood-2012-05-431460 1:CAS:528:DC%2BC38XhsFKku7rN
    • Kwong YL, Kim WS, Lim ST, et al. SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia lymphoma study group. Blood. 2012;120(15):2973-80.
    • (2012) Blood , vol.120 , Issue.15 , pp. 2973-2980
    • Kwong, Y.L.1    Kim, W.S.2    Lim, S.T.3
  • 11
    • 82955217787 scopus 로고    scopus 로고
    • Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type
    • 21984805 10.1182/blood-2011-05-354142 1:CAS:528:DC%2BC3MXhs1ansbzL
    • Suzuki R, Yamaguchi M, Izutsu K, et al. Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type. Blood. 2011;118:6018-22.
    • (2011) Blood , vol.118 , pp. 6018-6022
    • Suzuki, R.1    Yamaguchi, M.2    Izutsu, K.3
  • 12
    • 84865000830 scopus 로고    scopus 로고
    • Serum beta2-microglobin is a predictor of prognosis in patients with upper aero digestive tract NK/T-cell lymphoma
    • 22373550 10.1007/s00277-012-1434-1 1:CAS:528:DC%2BC38XhtVSlsLjP
    • Li ZM, Zhu YJ, Sun J, et al. Serum beta2-microglobin is a predictor of prognosis in patients with upper aero digestive tract NK/T-cell lymphoma. Ann Hematol. 2012;91(8):1265-70.
    • (2012) Ann Hematol , vol.91 , Issue.8 , pp. 1265-1270
    • Li, Z.M.1    Zhu, Y.J.2    Sun, J.3
  • 13
    • 38149076482 scopus 로고    scopus 로고
    • Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: A review
    • 17906988 10.1080/13547500701674063 1:CAS:528:DC%2BD1cXksVKktA%3D%3D
    • Bien E, Balcerska A. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review. Biomarkers. 2008;13(1):1-26.
    • (2008) Biomarkers , vol.13 , Issue.1 , pp. 1-26
    • Bien, E.1    Balcerska, A.2
  • 14
    • 0025779931 scopus 로고
    • Soluble interleukin-2 receptors in patients with nasopharyngeal carcinoma
    • 1848475 10.1002/1097-0142(19910415)67:8<2180: AID-CNCR2820670829>3. 0.CO;2-T 1:STN:280:DyaK3M7mvVWitA%3D%3D
    • Lai KN, Ho S, Leung JC, Tsao SY. Soluble interleukin-2 receptors in patients with nasopharyngeal carcinoma. Cancer. 1991;67(8):2180-5.
    • (1991) Cancer , vol.67 , Issue.8 , pp. 2180-2185
    • Lai, K.N.1    Ho, S.2    Leung, J.C.3    Tsao, S.Y.4
  • 16
    • 0025777606 scopus 로고
    • Serum soluble interleukin-2 (IL-2) receptor levels in women with breast carcinoma and its correlation with IL-2 receptor expression on blood lymphocytes and lymphocytic infiltration within the tumour
    • 2044083 10.1007/BF01756142 1:STN:280:DyaK3M3ls1aisw%3D%3D
    • Sharma S, Saha K, Shinghal RN, Malik GB. Serum soluble interleukin-2 (IL-2) receptor levels in women with breast carcinoma and its correlation with IL-2 receptor expression on blood lymphocytes and lymphocytic infiltration within the tumour. Cancer Immunol Immunother. 1991;33(3):198-202.
    • (1991) Cancer Immunol Immunother , vol.33 , Issue.3 , pp. 198-202
    • Sharma, S.1    Saha, K.2    Shinghal, R.N.3    Malik, G.B.4
  • 17
    • 0027459983 scopus 로고
    • High serum and ascitic soluble interleukin-2 receptor α levels in advanced epithelial ovarian cancer
    • Barton DP, Blanchard DK, Michelini-Norris B, et al. High serum and ascitic soluble interleukin-2 receptor a levels in advanced epithelial ovarian cancer. Blood. 1993;81(2):424-9. (Pubitemid 23027160)
    • (1993) Blood , vol.81 , Issue.2 , pp. 424-429
    • Barton, D.P.J.1    Blanchard, D.K.2    Michelini-Norris, B.3    Nicosia, S.V.4    Cavanagh, D.5    Djeu, J.Y.6
  • 19
    • 0025764781 scopus 로고
    • Soluble interleukin 2 receptor in lung cancer: An indirect marker of tumor activity?
    • 2036827 10.1378/chest.99.6.1433 1:STN:280:DyaK3M3ktlCntA%3D%3D
    • Buccheri G, Marino P, Preatoni A, et al. Soluble interleukin 2 receptor in lung cancer: an indirect marker of tumor activity? Chest. 1991;99(6):1433-7.
    • (1991) Chest , vol.99 , Issue.6 , pp. 1433-1437
    • Buccheri, G.1    Marino, P.2    Preatoni, A.3
  • 20
    • 0023944398 scopus 로고
    • Serum interleukin 2 receptor levels in childhood acute lymphoblastic leukemia
    • 3128348 1:STN:280:DyaL1c7osVWqtg%3D%3D
    • Pui CH, Ip SH, Iflah S, et al. Serum interleukin 2 receptor levels in childhood acute lymphoblastic leukemia. Blood. 1988;71(4):1135-7.
    • (1988) Blood , vol.71 , Issue.4 , pp. 1135-1137
    • Pui, C.H.1    Ip, S.H.2    Iflah, S.3
  • 21
    • 34547691044 scopus 로고    scopus 로고
    • Hemophagocytic syndromes
    • DOI 10.1016/j.blre.2007.05.001, PII S0268960X07000240
    • Janka G. Hemophagocytic syndromes. Blood Rev. 2007;21:245-53. (Pubitemid 47212601)
    • (2007) Blood Reviews , vol.21 , Issue.5 , pp. 245-253
    • Janka, G.E.1
  • 25
    • 79957516735 scopus 로고    scopus 로고
    • Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: A single-institution experience
    • 21599590 10.3109/10428194.2011.561388 1:CAS:528:DC%2BC3MXmtl2msbg%3D
    • Huang H, Lin Z, Lin X, et al. Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience. Leuk Lymphoma. 2011;52:1041-8.
    • (2011) Leuk Lymphoma , vol.52 , pp. 1041-1048
    • Huang, H.1    Lin, Z.2    Lin, X.3
  • 26
    • 0042449063 scopus 로고    scopus 로고
    • Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI sponsored international working group
    • 10561185 1:STN:280:DC%2BD3c%2FivF2itg%3D%3D
    • Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI sponsored international working group. J Clin Oncol. 1999;17:1244.
    • (1999) J Clin Oncol , vol.17 , pp. 1244
    • Cheson, B.D.1    Horning, S.J.2    Coiffier, B.3
  • 27
    • 0034007146 scopus 로고    scopus 로고
    • Clinical significance of serum soluble interleukin 2 receptor-α in esophageal squamous cell carcinoma
    • Wang Liang-Shun, Chow Kuan-Chih, Li Wing-Yin, et al. Clinical significance of serum soluble interleukin 2 receptor-a in esophageal squamous cell carcinoma. Clin Cancer Res. 2000;6:1445-51. (Pubitemid 30226233)
    • (2000) Clinical Cancer Research , vol.6 , Issue.4 , pp. 1445-1451
    • Wang, L.-S.1    Chow, K.-C.2    Li, W.-Y.3    Liu, C.-C.4    Wu, Y.-C.5    Huang, M.-H.6
  • 29
    • 0023907493 scopus 로고
    • Interleukin-2: Inception, impact, and implications
    • 3131876 10.1126/science.3131876 1:CAS:528:DyaL1cXkt1Whtrs%3D
    • Smith KA. Interleukin-2: inception, impact, and implications. Science. 1988;240:1169-76.
    • (1988) Science , vol.240 , pp. 1169-1176
    • Smith, K.A.1
  • 30
    • 0022536230 scopus 로고
    • The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes
    • 3008337 10.1126/science.3008337 1:CAS:528:DyaL2sXjs1ar
    • Waldmann TA. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science. 1986;232:727-32.
    • (1986) Science , vol.232 , pp. 727-732
    • Waldmann, T.A.1
  • 32
    • 0025077169 scopus 로고
    • The soluble interleukin-2 receptor: Biology, function, and clinical application
    • Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med. 1990;113:619-27. (Pubitemid 20346191)
    • (1990) Annals of Internal Medicine , vol.113 , Issue.8 , pp. 619-627
    • Rubin, L.A.1    Nelson, D.L.2
  • 33
    • 61649088127 scopus 로고    scopus 로고
    • Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy
    • 19074749 10.1093/annonc/mdn677 1:STN:280:DC%2BD1M7mvVajsg%3D%3D
    • Ennishi D, Yokoyama M, Terui Y, et al. Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy. Ann Oncol. 2009;20:526-33.
    • (2009) Ann Oncol , vol.20 , pp. 526-533
    • Ennishi, D.1    Yokoyama, M.2    Terui, Y.3
  • 34
    • 80052623454 scopus 로고    scopus 로고
    • Soluble IL-2R alpha facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma
    • 21719603 10.1182/blood-2011-03-340885 1:CAS:528:DC%2BC3MXht1ansL3P
    • Yang ZZ, Grote DM, Ziesmer SC, et al. Soluble IL-2R alpha facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma. Blood. 2011;118:2809-20.
    • (2011) Blood , vol.118 , pp. 2809-2820
    • Yang, Z.Z.1    Grote, D.M.2    Ziesmer, S.C.3
  • 35
    • 0035141983 scopus 로고    scopus 로고
    • A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma
    • DOI 10.1034/j.1600-0609.2001.00334.x
    • Niitsu N, Iijima K, Chizuka A. A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma. Eur J Haematol. 2001;66:24-30. (Pubitemid 32099406)
    • (2001) European Journal of Haematology , vol.66 , Issue.1 , pp. 24-30
    • Niitsu, N.1    Iijima, K.2    Chizuka, A.3
  • 36
    • 84862791825 scopus 로고    scopus 로고
    • Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ, and αβ/γδ T-cell origin: A comprehensive clinicopathologic and phenotypic study
    • 22314189 10.1097/PAS.0b013e31824433d8
    • Pongpruttipan T, Sukpanichnant S, Assanasen T, et al. Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ, and αβ/γδ T-cell origin: a comprehensive clinicopathologic and phenotypic study. Am J Surg Pathol. 2012;36(4):481-99.
    • (2012) Am J Surg Pathol , vol.36 , Issue.4 , pp. 481-499
    • Pongpruttipan, T.1    Sukpanichnant, S.2    Assanasen, T.3
  • 37
    • 84880717292 scopus 로고    scopus 로고
    • Clinical significance of serum-soluble interleukin-2 receptor in patients with follicular lymphoma
    • 23747081 10.1016/j.clml.2013.03.014 1:CAS:528:DC%2BC3sXptFGms7s%3D
    • Yoshizato T, Nannya Y, Imai Y, et al. Clinical significance of serum-soluble interleukin-2 receptor in patients with follicular lymphoma. Clin Lymphoma Myeloma Leuk. 2013;13(4):410-6.
    • (2013) Clin Lymphoma Myeloma Leuk , vol.13 , Issue.4 , pp. 410-416
    • Yoshizato, T.1    Nannya, Y.2    Imai, Y.3
  • 38
    • 51449098773 scopus 로고    scopus 로고
    • Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis
    • 18615554 10.1002/ajh.21236 1:CAS:528:DC%2BD1cXhtF2qsr7M
    • Olin RL, Nichols KE, Naghashpour M, et al. Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis. Am J Hematol. 2008;83(9):747-9.
    • (2008) Am J Hematol , vol.83 , Issue.9 , pp. 747-749
    • Olin, R.L.1    Nichols, K.E.2    Naghashpour, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.